Compare SOPH & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | EIC |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 293.8M |
| IPO Year | 2021 | 2019 |
| Metric | SOPH | EIC |
|---|---|---|
| Price | $4.74 | $11.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $14.00 |
| AVG Volume (30 Days) | 99.0K | ★ 287.7K |
| Earning Date | 11-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | ★ 13.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.14 |
| Revenue | ★ $73,297,000.00 | $59,262,402.00 |
| Revenue This Year | $18.32 | $37.84 |
| Revenue Next Year | $15.61 | $23.33 |
| P/E Ratio | ★ N/A | $10.00 |
| Revenue Growth | 13.66 | ★ 44.30 |
| 52 Week Low | $2.58 | $10.81 |
| 52 Week High | $5.30 | $16.39 |
| Indicator | SOPH | EIC |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 50.51 |
| Support Level | $4.60 | $11.00 |
| Resistance Level | $4.95 | $11.44 |
| Average True Range (ATR) | 0.26 | 0.21 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 28.95 | 85.14 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.